INMD Valuation

Inmode Ltd

Add to Watchlist

Advanced Chart

14.940

+0.02(0.134%)1D

Overview
Forecast
Valuation
Earnings

INMD Relative Valuation

INMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INMD is overvalued; if below, it's undervalued.

Historical Valuation

Inmode Ltd (INMD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.31 is considered Undervalued compared with the five-year average of 15.47. The fair price of Inmode Ltd (INMD) is between 24.16 to 45.78 according to relative valuation methord. Compared to the current price of 14.92 USD , Inmode Ltd is Undervalued By 38.24%.

Relative Value

Fair Zone

24.16-45.78

Current Price：14.92

38.24%

Undervalued

9.25

Trailing

Forward

4.62

EV/EBITDA

Inmode Ltd. (INMD) has a current EV/EBITDA of 4.62. The 5-year average EV/EBITDA is 11.04. The thresholds are as follows: Strongly Undervalued below -2.95, Undervalued between -2.95 and 4.04, Fairly Valued between 18.04 and 4.04, Overvalued between 18.04 and 25.04, and Strongly Overvalued above 25.04. The current Forward EV/EBITDA of 4.62 falls within the Historic Trend Line -Fairly Valued range.

4.64

EV/EBIT

Inmode Ltd. (INMD) has a current EV/EBIT of 4.64. The 5-year average EV/EBIT is 11.20. The thresholds are as follows: Strongly Undervalued below -3.17, Undervalued between -3.17 and 4.02, Fairly Valued between 18.39 and 4.02, Overvalued between 18.39 and 25.58, and Strongly Overvalued above 25.58. The current Forward EV/EBIT of 4.64 falls within the Historic Trend Line -Fairly Valued range.

2.52

Inmode Ltd. (INMD) has a current PS of 2.52. The 5-year average PS is 5.96. The thresholds are as follows: Strongly Undervalued below -0.47, Undervalued between -0.47 and 2.75, Fairly Valued between 9.18 and 2.75, Overvalued between 9.18 and 12.40, and Strongly Overvalued above 12.40. The current Forward PS of 2.52 falls within the Undervalued range.

0.00

P/OCF

Inmode Ltd. (INMD) has a current P/OCF of 0.00. The 5-year average P/OCF is 10.31. The thresholds are as follows: Strongly Undervalued below -12.70, Undervalued between -12.70 and -1.20, Fairly Valued between 21.81 and -1.20, Overvalued between 21.81 and 33.32, and Strongly Overvalued above 33.32. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Inmode Ltd. (INMD) has a current P/FCF of 0.00. The 5-year average P/FCF is 10.00. The thresholds are as follows: Strongly Undervalued below -12.32, Undervalued between -12.32 and -1.16, Fairly Valued between 21.15 and -1.16, Overvalued between 21.15 and 32.31, and Strongly Overvalued above 32.31. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Inmode Ltd (INMD) has a current Price-to-Book (P/B) ratio of 1.50. Compared to its 3-year average P/B ratio of 3.13 , the current P/B ratio is approximately -52.06% higher. Relative to its 5-year average P/B ratio of 5.91, the current P/B ratio is about -74.59% higher. Inmode Ltd (INMD) has a Forward Free Cash Flow (FCF) yield of approximately 10.83%. Compared to its 3-year average FCF yield of 9.14%, the current FCF yield is approximately 18.46% lower. Relative to its 5-year average FCF yield of 7.27% , the current FCF yield is about 49.00% lower.

1.49

P/B

Median3y

3.13

Median5y

5.91

11.03

FCF Yield

Median3y

9.14

Median5y

7.27

Competitors Valuation Multiple

The average P/S ratio for INMD's competitors is 48.95, providing a benchmark for relative valuation. Inmode Ltd Corp (INMD) exhibits a P/S ratio of 2.52, which is -94.85% above the industry average. Given its robust revenue growth of 10.59%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Kestra Medical Technologies Ltd

Pulse Biosciences Inc

261.71

1.05B

Performance Decomposition

Market capitalization of INMD decreased by 10.71% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 86.45M to 95.60M.

The secondary factor is the Margin Expansion, contributed 1.52%to the performance.

Overall, the performance of INMD in the past 1 year is driven by Revenue Growth. Which is more sustainable.

10.59%

86.45M → 95.60M

Revenue Growth

1.52%

27.55 → 27.97

Margin Expansion

-22.82%

7.58 → 5.85

P/E Change

-10.71%